Weekly Roundup: 15 Health Press Releases You Need To See
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes As a rapid-acting insulin, Merilo ...
Ozempic, Wegovy coverage demand adds to employer health-insurance costs
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
One of the hottest retention factors in 2025 comes with a big cost
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their employers.
Employer-Sponsored GLP-1 Coverage Becomes Critical for Talent Retention and Acquisition, New 9amHealth Survey Finds
As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey ...
Investing16d
Instacart (Maplebear Inc.) (CART)
SAN FRANCISCO , Oct. 15, 2024 /PRNewswire/ -- Instacart (NASDAQ: NASDAQ:CART) today announced it will report its third quarter 2024 financial results after market close on... Together, Instacart ...
Drug Store News26d
FDA proposes requiring At-a-Glance nutrition information on front of packaged foods
The Food and Drug Administration announced that it is proposing to require a front-of-package nutrition label for most packaged foods. This proposal plays a key role in the agency’s nutrition ...
Medindia1mon
Glooko Secures Reimbursement for Remote Monitoring of Gestational Diabetes in France
PALO ALTO, Calif., Jan. 21, 2025 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical ...